Clinical Trial Diversity-Will We Know It When We See It?

Tanvee Varma; Cary P Gross; Jennifer E Miller

doi:10.1001/jamaoncol.2023.0143

Clinical Trial Diversity-Will We Know It When We See It?

JAMA Oncol. 2023 Jun 1;9(6):765-767. doi: 10.1001/jamaoncol.2023.0143.

Authors

Tanvee Varma¹, Cary P Gross^{1

2}, Jennifer E Miller^{1

3}

Affiliations

¹ Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
² National Clinician Scholars Program, Yale School of Medicine, New Haven, Connecticut.
³ Yale Equity Research and Innovation Center (ERIC), New Haven, Connecticut.

PMID: 37022678
DOI: 10.1001/jamaoncol.2023.0143

No abstract available

Plain language summary

This Editorial discusses the existing policy efforts in the US for ensuring adequate racial and ethnic diversity in clinical trials, identifies barriers to consistency and acceptable representation, and suggests measures to address them.

Publication types

Research Support, N.I.H., Extramural
Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Clinical Trials as Topic
Cultural Diversity*
Ethnicity*
Humans
Racial Groups*
United States